BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8069096)

  • 1. Recent incidence trends imply a nonmetastasizing form of invasive melanoma.
    Burton RC; Armstrong BK
    Melanoma Res; 1994 Apr; 4(2):107-13. PubMed ID: 8069096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current melanoma epidemic: a nonmetastasizing form of melanoma?
    Burton RC; Armstrong BK
    World J Surg; 1995; 19(3):330-3. PubMed ID: 7638981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006.
    Baade P; Meng X; Youlden D; Aitken J; Youl P
    Int J Cancer; 2012 Jan; 130(1):170-8. PubMed ID: 21344376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of public education and the implications with regard to nonprogressive thin melanomas.
    Burton RC
    Curr Opin Oncol; 1995 Mar; 7(2):170-4. PubMed ID: 7756382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary malignant melanoma of skin in four regions of New Zealand.
    Cooke K; McNoe B; Hursthouse M; Taylor R
    N Z Med J; 1992 Aug; 105(939):303-6. PubMed ID: 1501812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
    van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
    Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of a melanoma epidemic.
    Burton RC; Coates MS; Hersey P; Roberts G; Chetty MP; Chen S; Hayes MH; Howe CG; Armstrong BK
    Int J Cancer; 1993 Nov; 55(5):765-70. PubMed ID: 8244573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ and invasive melanoma in a high-risk, New Zealand, population: A population-based study.
    Elwood JM; Kim SJ; Ip KH; Oakley A; Rademaker M
    Australas J Dermatol; 2019 Feb; 60(1):38-44. PubMed ID: 30051460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extremely high levels of melanoma in Tauranga, New Zealand: possible causes and comparisons with Australia and the northern hemisphere.
    Salmon PJ; Chan WC; Griffin J; McKenzie R; Rademaker M
    Australas J Dermatol; 2007 Nov; 48(4):208-16. PubMed ID: 17956477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma in Western Australia 1975-76 to 1980-81: trends in demographic and pathological characteristics.
    English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; ten Seldam RE
    Int J Cancer; 1986 Feb; 37(2):209-15. PubMed ID: 3943920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thick malignant melanoma is a long-term problem.
    Asquith PR; Barnett JM; Lockett BK
    N Z Med J; 1999 Aug; 112(1094):313-6. PubMed ID: 10493441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma in Western Australia in 1980-81: incidence and characteristics of histological types.
    English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; Ten Seldam RE
    Pathology; 1987 Oct; 19(4):383-92. PubMed ID: 3444664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world.
    Jones WO; Harman CR; Ng AK; Shaw JH
    World J Surg; 1999 Jul; 23(7):732-5. PubMed ID: 10390596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in incidence of thick, thin and in situ melanoma in Europe.
    Sacchetto L; Zanetti R; Comber H; Bouchardy C; Brewster DH; Broganelli P; Chirlaque MD; Coza D; Galceran J; Gavin A; Hackl M; Katalinic A; Larønningen S; Louwman MWJ; Morgan E; Robsahm TE; Sanchez MJ; Tryggvadóttir L; Tumino R; Van Eycken E; Vernon S; Zadnik V; Rosso S
    Eur J Cancer; 2018 Mar; 92():108-118. PubMed ID: 29395684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe.
    Garbe C; McLeod GR; Buettner PG
    Cancer; 2000 Sep; 89(6):1269-78. PubMed ID: 11002222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031.
    Whiteman DC; Green AC; Olsen CM
    J Invest Dermatol; 2016 Jun; 136(6):1161-1171. PubMed ID: 26902923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994-2004.
    Richardson A; Fletcher L; Sneyd M; Cox B; Reeder AI
    N Z Med J; 2008 Aug; 121(1279):18-26. PubMed ID: 18709044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.